United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr reddy's laboratories (uk) ltd - chlordiazepoxide hydrochloride - oral capsule - 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol laboratories ltd - amoxicillin trihydrate - oral capsule - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - chlordiazepoxide hydrochloride - oral capsule - 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - chlordiazepoxide hydrochloride - oral capsule - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ranbaxy (uk) ltd - chlordiazepoxide hydrochloride - oral capsule - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr reddy's laboratories (uk) ltd - chlordiazepoxide hydrochloride - oral capsule - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - chlordiazepoxide hydrochloride - oral capsule - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - chlordiazepoxide hydrochloride - oral capsule - 10mg

Ireland - English - HPRA (Health Products Regulatory Authority)

noridem enterprises ltd - ondansetron - solution for injection - 2 milligram(s)/millilitre - serotonin (5ht3) antagonists; ondansetron

United Kingdom - English - myHealthbox

noridem enterprises ltd - teicoplanin - powder and solvent for solution for injection/infusion or oral solution - 200,000 iu - glycopeptide antibacterials - it is indicated in adults and in children from birth for the parenteral treatment of the following infections (see sections 4.2, 4.4 and 5.1): • complicated skin and soft tissue infections, • bone and joint infections, • hospital acquired pneumonia, • community acquired pneumonia, • complicated urinary tract infections, • infective endocarditis, • peritonitis associated with continuous ambulatory peritoneal dialysis (capd) • bacteraemia that occurs in association with any of the indications listed above.